Amanote Research
Register
Sign In
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172
doi 10.1021/acschembio.5b00647.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
HCV NS3/4A Protein Complex
Science-Business eXchange
Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Synthesis of HCV Protease Inhibitor MK-6325
Synfacts
In Vitro Susceptibility of HCV Genotype 1 Through 6 Clinical Isolates to the Pan-Genotypic NS3/4A Inhibitor Voxilaprevir
Journal of Clinical Microbiology
Microbiology
Drug Resistance Against HCV NS3/4A Inhibitors Is Defined by the Balance of Substrate Recognition Versus Inhibitor Binding
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor
Antiviral Therapy
Infectious Diseases
Pharmacology
The Discovery and Development of Boceprevir: A Novel, First-Generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease
Journal of Clinical and Translational Hepatology
